Experienced in Retinal Artery Occlusion

Oliver A. Gross

Robert Koch Str. 40, 
Goettingen, NI, DE 
Experienced in Retinal Artery Occlusion
Robert Koch Str. 40, 
Goettingen, NI, DE 
OverviewLocationsClinical Research

Overview

Oliver Gross practices in Goettingen, Germany. Mr. Gross is rated as an Experienced expert by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Alport Syndrome, Interstitial Nephritis, Chronic Kidney Disease, Goodpasture Syndrome, and Kidney Transplant.

His clinical research consists of co-authoring 94 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Retinal Artery Occlusion.

Gender
Male

Locations

Robert Koch Str. 40, Goettingen, NI 37075, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of Lademirsen (SAR339375) for Subcutaneous Injection Administered Every Week in Patients With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of Lademirsen (SAR339375) for Subcutaneous Injection Administered Every Week in Patients With Alport Syndrome
Enrollment Status: Terminated
Publish Date: September 11, 2025
Intervention Type: Drug
Study Drug: Iademirsen
Study Phase: Phase 2
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Enrollment Status: Completed
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
View 1 Less Clinical Trial

94 Total Publications

In Reply.
In Reply.
Journal: Deutsches Arzteblatt international
Published: July 22, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Gross's expertise for a condition
ConditionClose
    View All 24 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile